Ligand validation:8I61

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8I61_EDO_A_304	36%	97%	0.195	0.888	0.12	0.2	-	-	0	0	100%	1
8I61_EDO_A_303	24%	58%	0.312	0.946	0.21	1.35	-	-	1	0	100%	1
8I61_EDO_A_305	5%	38%	0.281	0.699	1.52	0.94	1	-	0	0	100%	1
4WS1_EDO_A_302	84%	54%	0.097	0.959	1.3	0.52	-	-	0	0	100%	1
4WS0_EDO_A_303	81%	67%	0.092	0.942	0.89	0.4	-	-	0	0	100%	1
8I68_EDO_A_304	41%	85%	0.179	0.892	0.21	0.53	-	-	4	0	100%	1
8I69_EDO_A_303	8%	98%	0.318	0.801	0.04	0.25	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.